BioNTech

GERMANY — BioNTech, the German biotech firm that partnered with Pfizer to develop COVID-19 vaccines, has announced a reduction in its 2023 revenue target due…

USA — Pfizer and BioNTech have recently unveiled promising results from their joint endeavor, a combined COVID-19 and influenza vaccine, in a Phase 1/2 study…

GERMANY — Germany’s pioneering biopharmaceutical company, BioNTech, has embarked on a transformative journey in the realm of infectious disease prevention, partnering with the Coalition for…

RWANDA— The Minister of Health, Dr. Yvan Butera, has welcomed the “Twinning Project,” a project funded by the European Union (EU) aimed at strengthening the…

RWANDA – Rwanda has acquired its first modular container prototype known as BioNTainers which uses mRNA technology to produce vaccines. The six mobile vaccine-production units…

AFRICA – BioNTech has initiated an early-stage study to evaluate its experimental malaria vaccine, BNT165b1, in humans. The effort is one of several focused on…

SINGAPORE —BioNTech’s Singapore affiliate, BioNTech Pharmaceuticals Asia Pacific, is set to acquire a GMP-certified manufacturing site in the country from Novartis Singapore Pharmaceutical Manufacturing. The…

GERMANY – German biotech company CureVac has filed a patent infringement lawsuit against rival BioNTech for work that it says contributed to the development of…

RWANDA – Rwanda has announced plans to begin the construction of an mRNA vaccine manufacturing facility in Kigali in partnership with German pharmaceutical firm BioNTech…